Co-Authors
This is a "connection" page, showing publications co-authored by Donald Jensen and Nancy Reau.
Connection Strength
2.812
-
The American Association for the Study of Liver Diseases: A history of the first 10 years and its presidents. Hepatology. 2022 09; 76(3):854-859.
Score: 0.875
-
Generic medications for hepatitis C. Liver Int. 2016 07; 36(7):925-8.
Score: 0.584
-
Sticker shock and the price of new therapies for hepatitis C: is it worth it? Hepatology. 2014 Apr; 59(4):1246-9.
Score: 0.497
-
Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin. Am J Gastroenterol. 2008 Aug; 103(8):1981-8.
Score: 0.337
-
Vanishing bile duct syndrome. Clin Liver Dis. 2008 Feb; 12(1):203-17, x.
Score: 0.326
-
Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
Score: 0.109
-
Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatology. Hepatology. 2016 12; 64(6):2210-2218.
Score: 0.037
-
Hepatitis C virus: a critical appraisal of new approaches to therapy. Hepat Res Treat. 2012; 2012:138302.
Score: 0.028
-
Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis. Gastroenterol Hepatol (N Y). 2006 Jul; 2(7):504-508.
Score: 0.018